Global Oncology Competitive Intelligence Lead

BioSpace; Cambridge (MA); Hybrid; USD 167,000 - 301,000; Full time

Benefits offered by this job

Healthcare benefits

Hybrid work model

Generous time off

Discretionary bonus potential

Job summary

Moderna is seeking a Global Competitive Intelligence Lead-Oncology to drive the Oncology CI strategy across inline brands and pipeline assets. You will partner with Commercial and Portfolio leadership to deliver foresight and actionable recommendations for positioning, scenario planning, and go-to-market planning globally.

The role requires 10+ years in CI or related roles, global experience, and strong collaboration across Medical Affairs, Market Access, Commercial, and Clinical Development.

Qualifications

• Bachelor’s degree required; advanced degree preferred.
• 10+ years in competitive intelligence or related roles in life sciences or pharma.
• Experience leading CI strategies at a global scale and cross-functional collaboration.

Responsibilities

• Own and lead global CI strategy for Oncology across geographies.
• Monitor competitor pipelines, regulatory strategies, and market trends.
• Deliver insights to inform product development, launches, and lifecycle management.
• Represent CI in global Commercial planning forums and align with leadership.

Skills

Competitive intelligence

Strategic insights

Cross-functional leadership

Vendor management

Stakeholder engagement

Education

Bachelor’s degree in Business, Marketing, Life Sciences, or related field

Advanced degree (MBA, MS, PhD)

Tools

AI-driven CI platforms

Digital dashboards

Job description

Moderna is seeking a Global Competitive Intelligence Lead-Oncology to drive the Oncology CI strategy across inline brands and pipeline assets. You will partner with Commercial and Portfolio leadership to deliver foresight and actionable recommendations for positioning, scenario planning, and go-to-market planning globally.

The role requires 10+ years in CI or related roles, global experience, and strong collaboration across Medical Affairs, Market Access, Commercial, and Clinical Development.